Allen, Clint et al
"Bortezomib-Induced Apoptosis with Limited Clinical Response Is Accompanied by Inhibition of Canonical but not Alternative Nuclear Factor-κB Subunits in Head and Neck Cancer." Clinical Cancer Research
14.13
(2008):
4175-4185.
Web. 28 Feb. 2021.
